Transcriptional consequences of topoisomerase inhibition

Molecular and Cellular Biology

Volumn 21, Issue 24, 2001, Pages 8437-8451

  Collins, I ^a   Weber, A ^a   Levens, D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; HELICASE; PROTEIN C FOS;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; DNA CONFORMATION; DNA SUPERCOILING; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RNA SYNTHESIS; TRANSCRIPTION REGULATION;

ANTINEOPLASTIC AGENTS; BASE SEQUENCE; BLOTTING, SOUTHERN; CAMPTOTHECIN; CELL LINE; CELL NUCLEUS; DNA DAMAGE; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; DOXORUBICIN; ENZYME INHIBITORS; GENES, MYC; HUMANS; MOLECULAR SEQUENCE DATA; PLASMIDS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); PROTEIN CONFORMATION; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0035200324     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.24.8437-8451.2001     Document Type: Article

References (75)

1. Nucleosomal structures of c-myc promoters with transcriptionally engaged RNA polymerase II
2. Camptothecin induces differentiation and stimulates the expression of differentiation-related genes in U-937 human promonocytic leukemia cells
3. 1 stimulates multiple protein interactions at a unique cis-element in the 3′-untranslated region of the hyaluronan receptor RHAMM mRNA
4. Functional interaction between human topoisomerase IIα and retinoblastoma protein
5. Influence of amsacrine (m-AMSA) on bulk and genespecific DNA damage and c-myc expression in MCF-7 breast tumor cells
6. Mechanistic aspects of type-I topoisomerases
7. p53 mutations in Raji cells: Characterization and localization relative to other Burkitt's lymphomas
8. Chromatin structure around the c-myc gene in Burkitts lymphomas with upstream and downstream translocation points
9. Expression of normal and translocated c-myc alleles in Burkitt's lymphoma cells: Evidence for different regulation
10. The block of elongation in c-myc exon 1 is abolished in Burkitt's lymphoma cell lines with variant translocation
11. Effects of camptothecin, an inhibitor of DNA topoisomerase I, on ribosomal gene structure and function in TG cells
12. DNA supercoiling in chromatin structure and gene expression
13. SWI/SNF chromatin remodeling requires changes in DNA topology
14. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin
15. Induction of DNA damage, inhibition of DNA synthesis and suppression of c-myc expression by the anthracycline analog, idarubicin (4-demethoxy-daunorubicin) in the MCF-7 breast tumor cell line
16. Promoter melting and TFIID complexes on Drosophila genes in vivo
17. The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53
18. Different topoisomerase II antitumor drugs direct similar specific long-range fragmentation of an amplified c-MYC gene locus in living cells and in high-salt-extracted nuclei
19. Translocation joins c-myc and immunoglobulin gamma 1 genes in a Burkitt lymphoma revealing a third exon in the c-myc oncogene
20. Generation of superhelical torsion by ATP-dependent chromatin remodeling activities
21. Mechanistic aspects of type-II topoiosmerase
22. Deacetylase activity associates with topoisomerase II and is necessary for etoposide-induced apoptosis
23. Stably maintained microdomain of localized unrestrained supercoiling at a Drosophila heat shock gene locus
24. Analysis of topoisomerase I and II cleavage sites on the Drosophila Actin and Hsp70 heat shock genes
25. Modification of DNA topoisomerase II activity via direct interactions with the cyclic adenosine-3′,5′-monophosphate response element-binding protein and related transcription factors
26. The block to transcriptional elongation within the human c-myc gene is determined in the promoter-proximal region
27. The cis-acting elements known to regulate c-myc expression ex vivo are not sufficient for correct transcription in vivo
28. Activation of topoisomerase II-mediated excision of chromosomal DNA loops during oxidative stress
29. Tumor cell death induced by topoisomerase-targeting drugs
30. Anticancer drugs that convert DNA topoisomerases into DNA-damaging agents
31. Supercoiling of the DNA template during transcription
32. The anti-cancer drug camptothecin inhibits elongation but stimulates initiation of RNA polymerase II transcription
33. The immunoglobulin heavy chain locus control region increases histone acetylation along linked c-myc genes
34. Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells
35. c-myc expression is activated by the immunoglobulin κ-enhancers from a distance of at least 30 kb but not by elements located within 50 kb of the unaltered c-myc locus in vivo
36. DNA topoisomerase I is involved in both repression and activation of transcription
37. Multiple single-stranded cis elements are associated with activated chromatin of the human c-myc gene in vivo
38. Role of histone N-terminal tails and their acetylation in nucleosome dynamics
39. Transport of torsional stress in DNA
40. The translocated c-myc oneogene of Raji Burkitt lymphoma cells is not expressed in human lymphoblastoid cells
41. Nucleosome linking number change controlled by acetylation of histones H3 and H4
42. Transcriptional down-regulation of c-myc expression in the MCF-7 breast tumor cell line by the topoisomerase II inhibitor, VM-26
43. Elongation and premature termination of transcripts initiated from c-fos and c-myc promoters show dissimilar patterns
44. Truncation does not abrogate transcriptional downregulation of the c-myc gene by sodium butyrate in Burkitt's lymphoma cells
45. Resolving the role of topoisomerase II in chromatin structure and function
46. Mammalian DNA topoisomerase I activity and poisoning by camptothecin are inhibited by simian virus 40 large T antigen
47. Differential effects of amsacrine and epipodophyllotoxins on topoisomerase II cleavage in the human c-myc protooncogene
48. Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme
49. The c-myc story: Where we've been, where we seem to be going
50. A topological approach to nucleosome structure and dynamics: The linking number paradox and other issues
51. Nucleosomal structure of active and inactive c-myc genes
52. Transcription enhancer identified near the human C mu immunoglobulin heavy chain gene is unavailable to the translocated c-myc gene in a Burkitt lymphoma
53. Posttranscriptional regulation of c-fos mRNA expression
54. Unwinding of chromatin by the SV40 large T antigen DNA helicase
55. Analysis of topoisomerase II-mediated DNA cleavage of the c-myc gene during HL60 differentiation
56. Stimulation of the topoisomerase II induced DNA cleavage sites in the c-myc protooncogene by antitumor drugs is associated with gene expression
57. Differentiation of human promonocytic leukemia U-937 cells with DNA topoisomerase II inhibitors: Induction of vimentin gene expression
58. A gene expression database for the molecular pharmacology of cancer
59. Gene expression within a chromatin domain: The role of core histone hyperacetylation
60. Targeting to transcriptionally active loci by the hydrophilic N-terminal domain of Drosophila DNA topoiosmerase I
61. Effects of translocations on transcription from PVT
62. Topoisomerase I enhances TFIID-TFIIA complex assembly during activation of transcription
63. DNA fragmentation as a consequence of cell cycle traverse in doxorubicin- and idarubicin-treated human lymphoma cells
64. Control of c-myc regulation in normal and neoplastic cells
65. Rapid induction of c-fos transcription reveals quantitative linkage of RNA polymerase II and DNA topoisomerase I enzyme activities
66. Preparation of genomic DNA from mammalian tissue
67. HTLV-1 Tax oncoprotein binds to DNA topoisomerase I and inhibits its catalytic activity
68. Posttranscriptional regulation of hsp70 expression in human cells: Effects of heat shock, inhibition of protein synthesis, and adenovirus infection on translation and mRNA stability
69. DNA microloops and microdomains: A general mechanism for transcription activation by torsional transmission
70. Histone deacetylase interacts directly with DNA topoisomerase II
71. Chromatin-remodelling factor CHRAC contains the ATPases ISWI and topoisomerase II
72. DNA topoisomerases
73. Transcription against an applied force
74. Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes